With a market cap of $161.3 billion, New York-based Pfizer Inc. (PFE) is a leading global biopharmaceutical company. Known ...

Pfizer (PFE) stock fell even as the company beat forecasts with its Q3 results and increased its full-year outlook.Find out ...

Pfizer's non-COVID product revenues surged 14% operationally last quarter. The oncology business delivered exceptional ...

Pfizer Inc.’s stock was unable to hold its early gains Tuesday and fell 2.4% after the company blew past estimates for the third quarter and raised its full-year guidance. The New York-based ...

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Pfizer (PFE – Research Report) today. The company’s shares ...

Taking full advantage of the stock market and investing with confidence ... the most attractive and most discounted stocks. New York-based Pfizer markets a wide range of drugs and vaccines.

NEW YORK (AP) — NEW YORK (AP) — Pfizer Inc. (PFE) on Tuesday reported third-quarter earnings of $4.47 billion. The New York-based company said it had net income of 78 cents per share.

Despite today's fall in Pfizer's share price, it beat my and Wall Street analysts' expectations for Q3 by a large margin. See ...

The stock was down 1.3% at 3:21 p.m. in New York. Pfizer’s shares have shed more than half their value since peaking in December 2021. Since then, Bourla has embarked on a $70 billion string of ...

Pfizer (NYSE:PFE – Get Free Report) is scheduled to announce its earnings results before the market opens on Tuesday, October ...